TY - JOUR
T1 - Layer by layer three-dimensional tissue epitaxy by cell-laden hydrogel droplets
AU - Moon, Sangjun
AU - Hasan, Syed K.
AU - Song, Young S.
AU - Xu, Feng
AU - Keles, Hasan Onur
AU - Manzur, Fahim
AU - Mikkilineni, Sohan
AU - Hong, Jong Wook
AU - Nagatomi, Jiro
AU - Haeggstrom, Edward
AU - Khademhosseini, Ali
AU - Demirci, Utkan
PY - 2010/2/1
Y1 - 2010/2/1
N2 - The ability to bioengineer three-dimensional (3D) tissues is a potentially powerful approach to treat diverse diseases such as cancer, loss of tissue function, or organ failure. Traditional tissue engineering methods, however, face challenges in fabricating 3D tissue constructs that resemble the native tissue microvasculature and microarchitectures. We have developed a bioprinter that can be used to print 3D patches of smooth muscle cells (5mm× 5mm×81μm) encapsulated within collagen. Current inkjet printing systems suffer from loss of cell viability and clogging. To overcome these limitations, we developed a system that uses mechanical valves to print high viscosity hydrogel precursors containing cells. The bioprinting platform that we developed enables (i) printing of multilayered 3D cell-laden hydrogel structures (16.2μm thick per layer) with controlled spatial resolution (proximal axis: 18.0±7.0μm and distal axis: 0.5±4.9μm), (ii) high-throughput droplet generation (1s per layer, 160 droplets/s), (iii) cell seeding uniformity (26±2cells/mm2 at 1 million cells/mL, 122±20cells/mm2 at 5 million cells/mL, and 216±38cells/mm2 at 10 million cells/mL), and (iv) long-term viability in culture (>90%, 14 days). This platform to print 3D tissue constructs may be beneficial for regenerative medicine applications by enabling the fabrication of printed replacement tissues.
AB - The ability to bioengineer three-dimensional (3D) tissues is a potentially powerful approach to treat diverse diseases such as cancer, loss of tissue function, or organ failure. Traditional tissue engineering methods, however, face challenges in fabricating 3D tissue constructs that resemble the native tissue microvasculature and microarchitectures. We have developed a bioprinter that can be used to print 3D patches of smooth muscle cells (5mm× 5mm×81μm) encapsulated within collagen. Current inkjet printing systems suffer from loss of cell viability and clogging. To overcome these limitations, we developed a system that uses mechanical valves to print high viscosity hydrogel precursors containing cells. The bioprinting platform that we developed enables (i) printing of multilayered 3D cell-laden hydrogel structures (16.2μm thick per layer) with controlled spatial resolution (proximal axis: 18.0±7.0μm and distal axis: 0.5±4.9μm), (ii) high-throughput droplet generation (1s per layer, 160 droplets/s), (iii) cell seeding uniformity (26±2cells/mm2 at 1 million cells/mL, 122±20cells/mm2 at 5 million cells/mL, and 216±38cells/mm2 at 10 million cells/mL), and (iv) long-term viability in culture (>90%, 14 days). This platform to print 3D tissue constructs may be beneficial for regenerative medicine applications by enabling the fabrication of printed replacement tissues.
UR - https://www.scopus.com/pages/publications/77951247563
U2 - 10.1089/ten.tec.2009.0179
DO - 10.1089/ten.tec.2009.0179
M3 - 文章
C2 - 19586367
AN - SCOPUS:77951247563
SN - 1937-3384
VL - 16
SP - 157
EP - 166
JO - Tissue Engineering - Part C: Methods
JF - Tissue Engineering - Part C: Methods
IS - 1
ER -